Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01422889 · ClinicalTrials.gov registry record
ION US Post-Approval Study
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 1,120
- Enrollment target
NCT01422889: Completed study, sponsored by Boston Scientific Corporation.
NCT01422889 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01422889 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 1,120 participants
- Enrollment target
Study Summary
The purpose of this study is to compile real-world clinical outcomes data for the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System in routine clinical practice.
Primary Outcome
Cardiac Death or myocardial infarction (CD/MI) in the ION registry population. For the protocol specified primary endpoint analysis including data pooled from the PERSEUS SV, PERSEUS WH and TE Prove patient populations please see the citations.
Interventions
- DEVICE ION™ Coronary Stent System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,120 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-02 |
What the finished NCT01422889 record still lists
NCT01422889 is an observational study that tracks outcomes without assigning an intervention. Its 1,120 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which ION™ Coronary Stent System is the first listed.
NCT01422889 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01422889 about?
NCT01422889 is a clinical study titled "ION US Post-Approval Study". The purpose of this study is to compile real-world clinical outcomes data for the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System in routine clinical practice.
What is the current status of trial NCT01422889?
This trial is currently completed. The enrollment target is 1,120 participants. The study started on 2011-09. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01422889?
The interventions under investigation include: ION™ Coronary Stent System (DEVICE).
Who is sponsoring clinical trial NCT01422889?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- NCT06618534 · 1,120 participants · Phase 2
Azithromycin for Meningococcal Carriage
- NCT07164131 · 1,120 participants · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia